Evigrade

Trimethoprim

Antibacterial, dihydrofolate reductase inhibitor

ATC code: J01EA01

Brand names: Proloprim, Primsol

Updated · Methodology

Indications

B

Urinary tract infection

Second line

Trimethoprim is used for uncomplicated urinary tract infection in adults when fosfomycin or nitrofurantoin are unsuitable. SEIMC restricts empirical use because of growing E. coli resistance in Spain (above 25% in most regions). Long-term use requires potassium and creatinine monitoring.

ICD-10: N39.0 · ICD-11: GC08

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Inhibits bacterial dihydrofolate reductase, the enzyme converting dihydrofolate to tetrahydrofolate needed for nucleotide synthesis. Active against most Enterobacteriaceae and Pneumocystis. In co-trimoxazole, potentiates the antibacterial effect of sulfamethoxazole. Blocks ENaC in distal renal tubules by the same mechanism as amiloride, causing potassium retention.

Safety

Contraindications

  • Severe renal impairment (eGFR below 15 mL/min)
  • Megaloblastic anaemia from folate deficiency
  • Combination with dofetilide (FDA Tikosyn 4.3)
  • Combination with methotrexate
  • Hyperkalaemia

Serious adverse effects

  • Hyperkalaemia (especially elderly)
  • Megaloblastic anaemia
  • Severe skin reactions (SJS, TEN)
  • Sudden cardiac death with spironolactone combo

Common adverse effects

  • Nausea, vomiting
  • Rash
  • Pruritus
  • Creatinine rise (artefactual)

Pregnancy: can you take Trimethoprim?

Folate antagonist – neural tube defect risk in first trimester. Use only when necessary with folic acid 5 mg/day.

Breastfeeding: can you take Trimethoprim?

Passes into milk. Breastfeeding possible in term infants older than 1 month.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Drug–drug interactions

3 pairs found. Sorted from critical to minor.

CriticalDofetilideClass III antiarrhythmic, selective IKr blocker

Mechanism

Trimethoprim inhibits renal OCT2 transporter clearing dofetilide. Levels double. Tikosyn Section 4.3 strict contraindication.

Symptoms

Torsades de pointes.

Management

Combination contraindicated.

Pair details →Dofetilide →

CriticalSpironolactonePotassium-sparing diuretics (mineralocorticoid receptor antagonists)

Mechanism

Trimethoprim blocks ENaC in collecting ducts – potassium retention. With spironolactone dual aldosterone blockade. Sudden death increase reported in the elderly.

Symptoms

Hyperkalaemia within 3-7 days.

Management

Combination contraindicated in patients over 65. In younger patients check K+ at 3-5 days.

Pair details →Spironolactone →

MajorEnalaprilAngiotensin-converting enzyme inhibitors (ACEi)

Mechanism

Dual K+-sparing effect: enalapril suppresses aldosterone, trimethoprim blocks ENaC. Hyperkalaemia.

Symptoms

Hyperkalaemia within 5 days.

Management

Check K+ and creatinine on day 5. Alternative – fosfomycin or nitrofurantoin for UTI.

Pair details →Enalapril →

Label mentions24 mentions

Verbatim lines from the interaction sections, in the language of the label

From this drug’s label

  • «Drug Interactions: Trimethoprim may inhibit the hepatic metabolism of phenytoin. Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin…»

    FDA, section 7 · Open on DailyMed

From other drugs’ labels

  • «Alteración del equilibrio electrolítico: No se recomienda el uso concomitante de losartán junto con diuréticos ahorradores de potasio, suplementos de potasio y sustitutos de la sal que contengan…»

    AEMPS, section 4.4 · Open on CIMA

  • «Medicamentos que producen reacciones adversas en la médula ósea: En el caso de los tratamientos con medicamentos que pueden producir reacciones adversas en la médula ósea (p. ej., sulfonamidas…»

    AEMPS, section 4.5 · Open on CIMA

  • «La co-administración de trimetoprim (160 mg dos veces al día), un inhibidor moderado de CYP2C8 y repaglinida (una dosis única de 0,25 mg) aumentó el valor AUC de repaglinida, Cmax y t1/2 (1,6 veces…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateCiclosporin
    «Combinaciones con mayor riesgo de nefrotoxicidad: Deberá tenerse precaución cuando se utilice ciclosporina junto con otros fármacos que presentan sinergia nefrotóxica como son: aminoglucósidos…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateDiclofenac
    «Fármacos que pueden causar una hiperpotasemia : El tratamiento concomitante con fármacos ahorradores de potasio, ciclosporina, tacrolimus o trimetoprim puede asociarse con un aumento de los niveles…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateEplerenone
    «Trimetoprim: La administración concomitante de trimetoprim con eplerenona incrementa el riesgo de hiperpotasemia. Se debe realizar la monitorización del potasio sérico y de la función renal…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateKetoprofen
    «Los fármacos que pueden promover hipercalemia como diuréticos ahorradores de potasio, inhibidores de la ECA, antagonistas de angiotensina II, sales de potasio, AINEs, heparinas (de bajo peso…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateLithium
    «Interacciones que aumentan los niveles de litio: Antibióticos (nitroimidazoles (ej. Metronidazol)): el uso concomitante puede aumentar las concentraciones séricas de litio debido a la reducción del…»

    AEMPS, section 4.5 · Open on CIMA

  • «Trimetoprim/sulfametoxazol: La administración concomitante de medicamentos que afectan la glucuronidación del MPA puede modificar la exposición al MPA. Por lo tanto, se recomienda precaución cuando…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateRamipril
    «Sales de potasio, heparina, diuréticos que retienen potasio y otros principios activos que elevan el potasio plasmático (por ejemplo, antagonistas de la angiotensina II, trimetoprim y en combinación…»

    AEMPS, section 4.5 · Open on CIMA

  • «Recomendación relativa a la administración conjunta: No se observaron cambios clínicamente significativos en la exposición de azitromicina o de los medicamentos administrados conjuntamente en los…»

    AEMPS, section 4.5 · Open on CIMA

  • «Pharmacokinetic Drug Interactions: Trimethoprim 22 to 28% NA»

    FDA, section 7 · Open on DailyMed

  • «Drug-Drug Interactions: Cimetidine: (see WARNINGS, CONTRAINDICATIONS ) Concomitant use of cimetidine is contraindicated. Cimetidine at 400 mg BID (the usual prescription dose) co-administered with…»

    FDA, section 7 · Open on DailyMed

  • «Fármacos que influyen en los niveles de ácido fólico: Los anticonceptivos orales, anticonvulsivos, fármacos antituberculosos, el alcohol, la glucarpidasa y los antagonistas del ácido fólico como el…»

    AEMPS, section 4.5 · Open on CIMA

  • «En base a los datos in vitro , no se esperan interacciones medicamentosas clínicamente importantes con inhibidores menos potentes de CYP 2C8 (p. ej., trimetoprim). La administración conjunta de…»

    AEMPS, section 4.5 · Open on CIMA

  • «Effect of Other Drugs on Mycophenolate Mofetil: Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin…»

    FDA, section 7 · Open on DailyMed

  • «Drugs that Affect Phenytoin Concentrations: Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim»

    FDA, section 7 · Open on DailyMed

  • «DRUG INTERACTIONS: Examples: Drugs that are known to inhibit CYP3A4 include antifungal agents (ketoconazole, itraconazole) and antibacterial agents (clarithromycin, erythromycin). Drugs that are…»

    FDA, section 7 · Open on DailyMed

  • «Effect of Other Drugs on Rifabutin Pharmacokinetics: Sulfamethoxazole-Trimethoprim 800/160 mg 300 mg once a day HIV-infected patients (12) ↔ ↓ AUC by 15–20%»

    FDA, section 7 · Open on DailyMed

  • «Antiinfecciosos: Sulfametoxazol/Trimetoprim 2»

    AEMPS, section 4.5 · Open on CIMA

  • «No se han observado interacciones farmacocinéticas clínicamente significativas entre sirolimus y ninguna de las siguientes sustancias: aciclovir, atorvastatina, digoxina, glibenclamida…»

    AEMPS, section 4.5 · Open on CIMA

  • «Drugs and Supplements Increasing Serum Potassium: trimethoprim»

    FDA, section 7 · Open on DailyMed

  • «Drug Interactions:: co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin»

    FDA, section 7 · Open on DailyMed

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Trimethoprim used for?

Trimethoprim is evaluated for the following indications with varying evidence strength: Urinary tract infection (evidence tier B). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Trimethoprim?

Common side effects of Trimethoprim (≥ 1 in 100): Nausea, vomiting, Rash, Pruritus, Creatinine rise (artefactual). See the Safety section for uncommon and serious reactions.

Is Trimethoprim safe during pregnancy?

Folate antagonist – neural tube defect risk in first trimester. Use only when necessary with folic acid 5 mg/day.

Is Trimethoprim compatible with breastfeeding?

Passes into milk. Breastfeeding possible in term infants older than 1 month.

Who should not take Trimethoprim?

Trimethoprim is contraindicated in: Severe renal impairment (eGFR below 15 mL/min); Megaloblastic anaemia from folate deficiency; Combination with dofetilide (FDA Tikosyn 4.3); Combination with methotrexate; Hyperkalaemia. Full list in the Safety section.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Amoxicillin + Clavulanic Acid, Amoxicillin, Azithromycin, Cefalexin, Cefditoren pivoxil, Clarithromycin, Erythromycin, Linezolid